PN stock news
This page provides real-time market news, earnings updates, and company announcements related to PN Smart Energy Limited (PN).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-07-07 19:37 EST
Trump Media's Chief Revenue Officer Turns to Staking Returns in Face of Crypto Market Slump
Bitget-RWA2025-12-02 00:38:20
ALNY Q4 Earnings Beat, Sales Miss Despite Y/Y Growth, Stock Down
Finviz2026-02-13 16:21:42
Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Finviz2026-02-17 12:03:44
Energy Vault Holdings (NRGV) Plunged by Over 24% This Week. Here is Why
Finviz2026-02-20 16:33:40
Celldex Announces Multiple Upcoming Presentations at AAAAI 2026 Supporting Barzolvolimab's First-in-Class and Best-in-Disease Profile
Finviz2026-02-23 13:04:05
Kymera Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Finviz2026-02-26 12:03:47
Intellia Rises on Q4 Earnings & Revenue Beat, Focuses on Pipeline
Finviz2026-02-27 17:18:48
Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM
Finviz2026-03-02 12:33:44
Envirotech Vehicles Inc. has confirmed that the company officially signed a securities purchase agreement with institutional investor Ya Ii Pn, Ltd. on March 6, 2026.
老虎证券2026-03-09 20:54:33
Envirotech Vehicles Inc. has confirmed that the company officially signed a securities purchase agreement with institutional investor Ya Ii Pn, Ltd. on March 6, 2026.
老虎证券2026-03-09 20:56:05
Coherent Demonstrates Technologies for Next-Generation Pluggable Transceivers at OFC 2026
Finviz2026-03-17 13:03:52
Coherent to Unveil Breakthrough AI-Scale Optical Innovations and Industry Leadership at OFC 2026
Finviz2026-03-17 13:18:11
Quantum Biopharma's 2025 Audited Year End Financial Results Maintain 'No Going Concern' Status
Finviz2026-03-27 12:12:46
Pasithea Therapeutics Announces Grant of Fast Track Designation by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) Causing Significant Morbidity
Finviz2026-04-01 11:06:41
NioCorp Reports Voting Results from Its 2025 Annual General Meeting
Finviz2026-04-06 20:30:43
Webull Announces Termination of Standby Equity Purchase Agreement
Finviz2026-04-07 12:33:47
Skycorp Solar Group Limited Announces 1-for-20 Reverse Share Split
Finviz2026-04-08 20:33:10
Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Moderate to Severe Asthma
Finviz2026-04-13 11:03:45
Celldex Announces Multiple Upcoming Presentations at AAAAI 2026 Supporting Barzolvolimab's First-in-Class and Best-in-Disease Profile
Finviz2026-02-23 13:04:05
Kymera Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Finviz2026-02-26 12:03:47
Intellia Rises on Q4 Earnings & Revenue Beat, Focuses on Pipeline
Finviz2026-02-27 17:18:48
Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM
Finviz2026-03-02 12:33:44
Envirotech Vehicles Inc. has confirmed that the company officially signed a securities purchase agreement with institutional investor Ya Ii Pn, Ltd. on March 6, 2026.
老虎证券2026-03-09 20:54:33
Envirotech Vehicles Inc. has confirmed that the company officially signed a securities purchase agreement with institutional investor Ya Ii Pn, Ltd. on March 6, 2026.
老虎证券2026-03-09 20:56:05
Coherent Demonstrates Technologies for Next-Generation Pluggable Transceivers at OFC 2026
Finviz2026-03-17 13:03:52
Coherent to Unveil Breakthrough AI-Scale Optical Innovations and Industry Leadership at OFC 2026
Finviz2026-03-17 13:18:11
Quantum Biopharma's 2025 Audited Year End Financial Results Maintain 'No Going Concern' Status
Finviz2026-03-27 12:12:46
Pasithea Therapeutics Announces Grant of Fast Track Designation by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) Causing Significant Morbidity
Finviz2026-04-01 11:06:41
NioCorp Reports Voting Results from Its 2025 Annual General Meeting
Finviz2026-04-06 20:30:43
Webull Announces Termination of Standby Equity Purchase Agreement
Finviz2026-04-07 12:33:47
Skycorp Solar Group Limited Announces 1-for-20 Reverse Share Split
Finviz2026-04-08 20:33:10
Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Moderate to Severe Asthma
Finviz2026-04-13 11:03:45
PN stock chart
PN stock detailsPN stock price change
On the last trading day, PN stock closed at 3.89 USD, with a price change of 0.26% for the day.
Trade spot stocks (24/7)Trade stock perps (up to 100x leverage)About Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
To provide deeper liquidity, a more transparent trading experience, and greater capital efficiency, Bitget officially launched its all-new spot stock product, Bitget Stocks 2.0, on June 2, 2026.
The new product is independently issued by licensed RWA protocol Reality, with Bitget providing strategic support and asset security safeguards. This marks a major upgrade to the stock trading experience.
Bitget is moving stock trading beyond the limits of traditional trading models by fully integrating stock assets into its margin and yield ecosystem.
Learn more